J+D Labs Pharma Manufacturing was acquired by Captek Softgel International on August 4, 2017
medical products Company

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2017. The largest medical products acquisition in 2017 was C. R. Bard - which was acquired by Becton Dickinson for $24.0B.

Join Mergr to view all 202 acquisitions of medical products companies in 2017, including 24 acquisitions by private equity firms, and 178 by strategics.

J+D Labs Pharma Manufacturing, Inc.

2710 Progress Street,
Vista, California 92081
United States,
(844) 453-5227
www.jdlabs.com

J+D Labs Pharma Manufacturing, Inc. is a manufacturer of health and wellness supplements producing more than 1,000 unique formulations. J+D Labs Pharma Manufacturing was founded in 1989 and is based in Vista, California.

Medical Products M&A - Last 3 Years

J+D Labs Pharma Manufacturing was acquired by Captek Softgel International on August 4, 2017.

Join Mergr to view this profile - and discover more medical products acquisitions of companies like J+D Labs Pharma Manufacturing.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.7K Private Equity Firms
  • 132K M&A Transactions
  • 141K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.